Set It and Forget It: 3 Monster Stocks Worth Holding Through Whatever Comes NextThe Motley Fool • 05/01/26
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 04/27/26
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 04/16/26
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.The Motley Fool • 04/14/26
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 04/02/26
Vertex Pharmaceuticals: Label Expansions For ALYFTREK And TRIKAFTA Plus Strong DemandSeeking Alpha • 04/02/26
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United StatesBusiness Wire • 04/01/26
Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise AnywayThe Motley Fool • 03/28/26
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?Zacks Investment Research • 03/20/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26